XML 50 R39.htm IDEA: XBRL DOCUMENT
v3.23.2

Variable Interest Entities (VIEs) (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Assets and Liabilities, Variable Interest Entities | The following table includes assets that can only be used to settle the liabilities of APC and its consolidated entities and VIEs, including Alpha Care and Accountable Health Care, and to which the creditors of ApolloMed have no recourse, and liabilities to which the creditors of APC, including Alpha Care and Accountable Health Care, have no recourse to the general credit of ApolloMed, as the primary beneficiary of the VIEs. These assets and liabilities, with the exception of the investment in a privately held entity that does not report net asset value per share and amounts due to affiliates, which are eliminated upon consolidation with NMM, are included in the accompanying consolidated balance sheets (in thousands). The assets and liabilities of the Company’s other consolidated VIEs were not considered significant.
| March 31, 2023 |  | December 31, 2022
Assets |  |  |
Current assets |  |  |
Cash and cash equivalents | $ | 96,018 |  |  | $ | 97,669 |
Investment in marketable securities | 1,538 |  |  | 4,543 |
Receivables, net | 14,369 |  |  | 11,503 |
Receivables, net – related party | 70,565 |  |  | 62,190 |
Income taxes receivable (restated) | — |  |  | 8,580 |
Other receivables | 1,268 |  |  | 1,236 |
Prepaid expenses and other current assets | 18,241 |  |  | 9,289 |
Loan receivable | — |  |  | 22 |
Loan receivable – related party | — |  |  | 2,125 |
Amount due from affiliates* | 33,979 |  |  | 30,340 |
Total current assets | 235,978 |  |  | 227,497 |
Non-current assets |  |  |
Land, property, and equipment, net | 110,829 |  |  | 106,486 |
Intangible assets, net | 51,667 |  |  | 53,964 |
Goodwill (restated) | 110,182 |  |  | 111,539 |
Income taxes receivable, non-current (restated) | 15,943 |  |  | 15,943 |
Investment in affiliates* | 375,614 |  |  | 304,755 |
Investments in other entities – equity method | 29,758 |  |  | 27,561 |
Investment in privately held entities | 405 |  |  | 405 |
Operating lease right-of-use assets | 4,961 |  |  | 6,503 |
Other assets | 3,513 |  |  | 4,169 |
Total non-current assets | 702,872 |  |  | 631,325 |
Total assets | $ | 938,850 |  |  | $ | 858,822 |
Current liabilities |  |  |
Accounts payable and accrued expenses | $ | 22,823 |  |  | $ | 23,632 |
Fiduciary accounts payable | 8,923 |  |  | 7,853 |
Medical liabilities | 43,948 |  |  | 48,100 |
Income taxes payable (restated) | 2,756 |  |  | — |
Dividends payable | 638 |  |  | 638 |
Current portion of long-term debt | 621 |  |  | 619 |
| March 31, 2023 |  | December 31, 2022
Finance lease liabilities | 579 |  |  | 594 |
Operating lease liabilities | 1,489 |  |  | 1,800 |
Total current liabilities | 81,777 |  |  | 83,236 |
Non-current liabilities |  |  |
Long-term debt, net of current portion and deferred financing costs | 27,965 |  |  | 26,645 |
Deferred tax liability (restated) | 3,680 |  |  | 4,591 |
Finance lease liabilities, net of current portion | 1,136 |  |  | 1,275 |
Operating lease liabilities, net of current portion | 6,136 |  |  | 7,484 |
Other long-term liabilities | 8,686 |  |  | 8,542 |
Total non-current liabilities | 47,603 |  |  | 48,537 |
Total liabilities | $ | 129,380 |  |  | $ | 131,773 |
*Investment in affiliates includes APC’s investment in ApolloMed, which is reflected as treasury shares and eliminated upon consolidation. Amount due from affiliates are receivables with ApolloMed’s subsidiaries and consolidated VIEs. As a result, these balances are eliminated upon consolidation and are not reflected on ApolloMed’s consolidated balance sheets as of March 31, 2023 and December 31, 2022.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -URI https://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685 + Details
Name: | us-gaap_ScheduleOfVariableInterestEntitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration